ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Allarity Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.87−0.02 (-2.46%)
Close on Oct 19, 2026
- Market cap
- $13.89M
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
8.1%
1M of 16M shares
Institutional holders
20
8 new, 2 sold out
Net institutional buying
0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| John M. Fife | 8,999,800 | – | 13G (passive) | Aug 19, 2024 |
| Olmsted Investments LLC | 10,000 | 28.60% | 13G (passive) | Aug 19, 2024 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of ALLR | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 331,509 | 2.08% | $427.65K | +103,425 | 0.00% |
| Vanguard Capital Management LLC | 171,795 | 1.08% | $221.62K | – | 0.00% |
| Geode Capital Management, LLC | 154,867 | 0.97% | $199.78K | −35,526 | 0.00% |
| State Street Corp | 137,600 | 0.86% | $177.50K | – | 0.00% |
| Militia Capital Management LLC | 98,978 | 0.62% | $127.68K | New | 0.00% |
| Citadel Advisors LLC | 91,748 | 0.58% | $118.36K | New | 0.00% |
| Vanguard Fiduciary Trust Co | 74,913 | 0.47% | $96.64K | – | 0.00% |
| Hrt Financial LP | 37,003 | 0.23% | $47 | New | 0.00% |
| Northern Trust Corp | 36,534 | 0.23% | $47.13K | −11,569 | 0.00% |
| Jane Street Group, LLC | 36,021 | 0.23% | $46.47K | New | 0.00% |
| Two Sigma Investments, LP | 27,492 | 0.17% | $35.47K | – | 0.00% |
| UBS Group AG | 26,589 | 0.17% | $34.30K | +3,431 | 0.00% |
| XTX Topco Ltd | 20,884 | 0.13% | $26.94K | −8,083 | 0.00% |
| Susquehanna International Group, Llp | 17,221 | 0.11% | $22.22K | New | 0.00% |
| Virtu Financial LLC | 15,322 | 0.10% | $20 | New | 0.00% |
| Tower Research Capital LLC (TRC) | 2,650 | 0.02% | $3.42K | New | 0.00% |
| Caitong International Asset Management Co., Ltd | 22 | 0.00% | $28 | +21 | 0.00% |
| FMR LLC | 13 | 0.00% | $17 | New | 0.00% |
| Danske Bank A/S | 1 | 0.00% | $1 | – | 0.00% |
| Jones Financial Companies Lllp | 1 | 0.00% | $1 | – | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 20 | 1M | 8.1% | 8 / 3 | 3 / 2 | 0M | 0M |
| Q1 2026 | 14 | 1M | 6.0% | 5 / 2 | 4 / 6 | 0M | 0M |
| Q4 2025 | 16 | 1M | 8.1% | 6 / 4 | 3 / 1 | 1M | 0M |
| Q3 2025 | 11 | 1M | 6.5% | 7 / 1 | 1 / 6 | 1M | 0M |
| Q2 2025 | 10 | 0M | 1.2% | 4 / 3 | 1 / 3 | 0M | 0M |
| Q1 2025 | 9 | 0M | 0.6% | 6 / 2 | 0 / 3 | 0M | 0M |
| Q4 2024 | 6 | 0M | 0.7% | 3 / 2 | 1 / 1 | 0M | 0M |
| Q3 2024 | 4 | 0M | 0.1% | 4 / 0 | 0 / 0 | 0M | 0M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of ALLR | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 171,795 | 1.08% | $221.62K | 0.00% | Jun 30, 2026 |
| Fidelity Extended Market Index Fund | 94,289 | 0.59% | $154.63K | 0.00% | May 31, 2026 |
| Fidelity Total Market Index Fund | 22,166 | 0.14% | $36.35K | 0.00% | May 31, 2026 |
| Fidelity Series Total Market Index Fund | 21,595 | 0.14% | $35.42K | 0.00% | May 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Thomas Jensen | CEO | 596,734 | 3.75% | May 14, 2026 |
| Jeremy R. Graff | See Remarks | 381,644 | 2.40% | Apr 30, 2026 |
| Jeffrey S. Ervin | CFO | 150,000 | 0.94% | Apr 30, 2026 |
| Alexander Epshinsky | CFO | 85,051 | 0.53% | Jan 24, 2025 |
| Jesper Hoeiland | Director | 25,000 | 0.16% | May 11, 2026 |
| Gerald W. McLaughlin | Director | 70,000 | 0.44% | May 7, 2026 |
| Laura Benjamin | Director | – | – | Jan 24, 2025 |
| Joseph Walter Vazzano | Director | – | – | Jan 24, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Thomas Jensen CEO | Jan 28, 2026 | Award | +200,000 | – | – | 596,734 |
| Gerald W. McLaughlin Director | Jan 28, 2026 | Award | +45,000 | – | – | 70,000 |
| Jeffrey S. Ervin CFO | Jan 28, 2026 | Award | +150,000 | – | – | 150,000 |
| Jeremy R. Graff See Remarks | Jan 28, 2026 | Award | +133,333 | – | – | 381,644 |
| Jesper Hoeiland Director | Jan 7, 2026 | Award | +25,000 | – | – | 25,000 |
| Jeremy R. Graff See Remarks | Jan 7, 2026 | Award | +133,333 | – | – | 381,644 |
| Jeremy R. Graff See Remarks | Sep 30, 2025 | Tax withholding | −14,613 | $1.58 | $23.09K | 24,881 |
| Jeremy R. Graff See Remarks | Sep 30, 2025 | Option exercise | +39,494 | – | – | 39,494 |
| Jeremy R. Graff CDO | Jan 22, 2025 | Award | +144,441 | – | – | 262,924 |
| Alexander Epshinsky CFO | Jan 22, 2025 | Award | +29,496 | – | – | 85,051 |
| Thomas Jensen CEO | Jan 22, 2025 | Award | +396,734 | – | – | 396,734 |
| Jeremy R. Graff See Remarks | Sep 30, 2024 | Award | +118,483 | $2.11 | $250.00K | 118,483 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.